Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nanjing Quzyme Biotechnology

Request full access

Synthetic biology-driven green biomanufacturing of enzyme catalysts

ChinaFounded 2014

About Nanjing Quzyme Biotechnology

Nanjing Quzyme Biotechnology Co., Ltd. is a high-tech enterprise focused on the research and development, production, and sale of special enzymes and functional chemicals. The company leverages synthetic biology to drive green biomanufacturing processes.

Founded in 2014, the company operates with a business model centered on providing enzyme catalysts and technology solutions for various industries. Its clientele includes sectors such as pharmaceuticals, food and beverage, and new materials. By utilizing advanced biocatalysis technology, Quzyme Biotechnology aims to replace traditional chemical synthesis methods, offering more environmentally friendly and efficient production routes. The company generates revenue through the direct sale of its enzyme products and by providing customized biocatalytic technology development services to its clients.

In July 2023, Nanjing Quzyme Biotechnology secured approximately CNY 100 million in a Series A financing round. The investment was led by a consortium of venture capital firms including Hermed Capital, Kangju Venture Capital, Nanling Venture Capital, KYT Investment, Solid Investment, and Huayao Equity, indicating strong investor confidence in its technology and market potential.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
12.0/100
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jul 2023 $14M $55M Kangju Venture Capital · KYT Investment · Huayao Equity · Hermed Capital ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Nanjing Quzyme Biotechnology website traffic

Latest recorded traffic for Nanjing Quzyme Biotechnology is 450 monthly website visits, down 67.9% over the last three months.

Latest monthly visits450 3-month web change-67.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nanjing Quzyme Biotechnology in its local ecosystem

Live from Dealroom

The Nanjing Quzyme Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Kangju Venture Capital
  • KYT Investment
  • Huayao Equity
  • Hermed Capital
  • Nanling Venture Capital
  • Solid Investment
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nanjing Quzyme Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nanjing Quzyme Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.